Compare OPAL & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPAL | LNSR |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medical Electronics |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 63.5M |
| IPO Year | 2021 | 2005 |
| Metric | OPAL | LNSR |
|---|---|---|
| Price | $2.22 | $8.19 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $2.72 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 182.1K | 121.7K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 650.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $348,975,000.00 | $58,435,000.00 |
| Revenue This Year | $12.84 | $10.06 |
| Revenue Next Year | $9.11 | $41.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.34 | 9.24 |
| 52 Week Low | $1.65 | $4.95 |
| 52 Week High | $2.87 | $12.96 |
| Indicator | OPAL | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 80.30 |
| Support Level | $2.04 | $5.25 |
| Resistance Level | $2.44 | $12.13 |
| Average True Range (ATR) | 0.20 | 0.40 |
| MACD | -0.03 | 0.31 |
| Stochastic Oscillator | 13.38 | 85.09 |
OPAL Fuels Inc is a fully integrated leader in the capture and conversion of biogas into low-carbon-intensity renewable natural gas and Renewable Power. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-decarbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas. The Company has three operating segments: RNG Fuel, Fuel Station Services, and Renewable Power.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.